Perspectives of Oncology Practitioners on Hormonal Treatment Following Chemoradiation for Cervical Cancer - Takeaways - MDSpire

Perspectives of Oncology Practitioners on Hormonal Treatment Following Chemoradiation for Cervical Cancer

  • By

  • Morgan S. Levy

  • Marilyn Huang

  • Charles S. Dietrich

  • Denise Fabian

  • April 14, 2026

  • 0 min

Share

  • 1

    Iatrogenic menopause from chemoradiotherapy in premenopausal patients with locally advanced cervical cancer can be effectively managed with hormonal therapy.

  • 2

    Despite guidelines recommending hormonal therapy, its use remains low among oncology practitioners treating cervical cancer survivors.

  • 3

    A survey of gynecologic and radiation oncologists revealed that most would prescribe hormonal therapy, but barriers to implementation persist.

  • 4

    Clinicians often cite lack of long-term management capacity and unawareness of guidelines as barriers to prescribing hormonal therapy.

  • 5

    Future efforts should focus on increasing awareness of guidelines and understanding barriers to enhance the prescribing of hormonal therapy.

Original Source(s)

Perspectives of Oncology Practitioners on Hormonal Treatment Following Chemoradiation for Cervical Cancer

  • by Morgan S. Levy, Marilyn Huang, Charles S. Dietrich, Denise Fabian

  • April 14, 2026

Related Content

Surgeons, Pregnancy, and Work Demands

Lack of workplace support linked to pregnancy outcomes.

Manual IVF Screening May Miss Additional Oocytes

Clinical study suggests automated system can recover mature oocytes overlooked during standard screening

ACOG Parts Ways With ACIP

“ACOG’s withdrawal from ACIP is not a withdrawal from our commitment to advancing vaccine science or to protecting patients’ health and safety."